AzTrials
AzTrials

Sleep DeprivationNCT05309473

Acoustic Stimulation During Restricted Sleep After Sleep Deprivation

A study testing Philips SmartSleep Acoustic Stimulation Device in people with Sleep Deprivation and Sleep Restriction, run by Walter Reed Army Institute of Research (WRAIR) at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if brief sounds or tones presented within a restricted period of recovery sleep after a period of sleep deprivation will enhance restorative properties and improve performance during a subsequent period of wakefulness. Read more about this study

Who is it for?
Ages 18 to 39 yearsHealthy volunteers can take part
What is being tested?
Philips SmartSleep Acoustic Stimulation Device
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
44 participants
Where
1 siteUnited States
Study dates
14 Mar 2022to Oct 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 39 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy men and non-pregnant, non-lactating women 18 to 39 years of age (inclusive)
  • Must demonstrate adequate comprehension of the protocol, by achieving a score of at least 80% correct on a short multiple-choice quiz. Individuals who fail to achieve a passing score on the initial quiz will be given one opportunity to retest after a review of protocol information. Individuals who fail the comprehension assessment for the second time will be disqualified.

Who cannot join

  • You must have learned English as your first language
  • You must have a body mass index (BMI) below 30 (this is a mathematical calculation of your height and weight)
  • You must not have current or a history of sleeping problems (for example, insomnia or sleep apnea), or symptoms that indicate a potential sleep disorder
  • You must get an average of 6-9 hours of sleep per night and maintain a normal sleep/wake schedule
  • You must not drink excessive amounts of caffeine, alcohol, or smoke cigarettes regularly
  • You must not be on certain medications (determined on a case by case basis)
Show all 11Show fewer
  • You must test negative for illicit drugs
  • Women must not be pregnant or nursing
  • You must not be participating in another ongoing clinical trial
  • You must have a social security number or tax identification number in order to be paid for screening and participation in the study
  • You cannot have a history of the following conditions: Cardiovascular disease, a neurologic disorder, pulmonary disease requiring inhaler use, kidney disease or kidney abnormalities, liver disease of liver abnormalities, a history of psychiatric disorder requiring hospitalization or medication within the last two years or for a continuous period of more than 6 months in the last ten years

Trial locations and contacts

1 site in 1 country.

United States1 site, 1 recruiting
  • Walter Reed Army Institute of Research

    Silver Spring, Maryland, 20910

    Ruthie Ratcliffe, 301-319-3131, ruthie.h.ratcliffe.civ@mail.mil

    Kajsa Carlsson, 301-319-9287, kajsa.e.carlsson.ctr@mail.mil

    Recruiting

Other trials in United States

About this study

Official title: Slow-wave Sleep Enhancement Using Acoustic Stimulation to Facilitate Performance Recovery During Restricted Sleep After Sleep Deprivation

The purpose of this study is to determine if brief sounds or tones presented within a restricted period of recovery sleep after a period of sleep deprivation will enhance restorative properties and improve performance during a subsequent period of wakefulness.

Being tested
Philips SmartSleep Acoustic Stimulation Device, Sham (no Acoustic Stimulation)
Medical subject headings
Sleep Deprivation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Philips SmartSleep Acoustic Stimulation DeviceDevice

    Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive acoustic stimulation during the four hours of sleep.

  • Sham (no Acoustic Stimulation)Device

    Prior to bedtime on the first two recovery nights, a Philips SmartSleep device will be applied to the head of each subject. Subjects will receive Sham (no acoustic stimulation) during the four hours of sleep.

Study groups in NCT05309473
Study groupRoleWhat they receive
Subjects Who Received Acoustic StimulationExperimentalFollowing 40 hours of deprivation participants will sleep for approximately a four hour recovery sleep period and receive acoustic stimulation via the Philips SmartSleep during slow-wave sleep. They will then sleep for second night of four hour recovery sleep and receive acoustic stimulation via the Philips Smart Sleep device during slow-wave sleep again.
Receives: Device: Philips SmartSleep Acoustic Stimulation Device
Subjects Who Received Sham (no Acoustic Stimulation)Sham comparatorFollowing 40 hours of deprivation participants will sleep for approximately a four hour recovery sleep period and receive Sham (no acoustic stimulation) via the Philips SmartSleep during slow-wave sleep. They will then sleep for second night of four hour recovery sleep and receive Sham (no acoustic stimulation) via the Philips Smart Sleep device during slow-wave sleep again.
Receives: Device: Sham (no Acoustic Stimulation)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure the effects of sleep deprivation/sleep restriction on performance using the Psychomotor Vigilance Task (PVT)

    Performed at approximately 75 minutes intervals throughout the sleep deprivation and recovery days

    Measured: 8 days

Secondary outcomes (7)
  1. Measure simple arithmetic processing using the Mathematical Processing Subtest of the Automated Neuropsychological Assessment Metrics 4 (ANAM4)

    Computer based series of mathematical calculations

    Measured: 5 days

  2. Measure current mood states using the Mood Analogue Scale (MAS)

    Computer based self adjective checklist of measure mood states

    Measured: 5 days

  3. Measure latency to sleep using the Maintenance of Wakefulness Test (MWT)

    Subjects will be escorted to their individual darkened, sound-attenuated bedrooms and allowed to lie down on their beds. They will be instructed to close their eyes and try to remain awake. Polysomnography will be monitored online.

    Measured: 5 days

  4. Measure alertness using the Karolinska Sleepiness Scale (KSS)

    Computer based self rated level of sleepiness

    Measured: 5 days

  5. Measure various aspects of mood using the Walter Reed Army Institute of Research (WRAIR) Mood Battery

    Computer based battery testing various aspects of mood

    Measured: 5 days

  6. Measure various aspects of Sleep and Wakefulness using Polysomnographic measurements with video

    Sleep will be measured during the night using polysomnography

    Measured: 5 days

  7. Measure various aspects of Sleep and Wakefulness using Actigraphy

    A watch-like device called an actigraph will measure movement to determine wake and sleep

    Measured: 22 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2022
  2. Study start14 Mar 2022
  3. Primary completionOct 2025 (estimated)
  4. Study completionOct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
44 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05309473
Sponsor's protocol ID
2901
Status last verified
Apr 2024
First submitted
17 Feb 2022
Last updated
23 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Philips SmartSleep Acoustic Stimulation Device in people with Sleep Deprivation and Sleep Restriction, run by Walter Reed Army Institute of Research (WRAIR) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact John D Hughes, MD (301-319-3214, john.d.hughes4.ctr@mail.mil), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure the effects of sleep deprivation/sleep restriction on performance using the Psychomotor Vigilance Task (PVT) (time frame: 8 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in